Elevated tissue factor pathway inhibitor delays thrombin generation in COVID-19 but is not associated with clinical outcomes
Open Access
- 29 April 2025
- journal article
- Published by Elsevier in Blood Vessels, Thrombosis & Hemostasis
- Vol. 2 (3)
Abstract
No abstract availableKeywords
Funding Information
- US Department of Veterans Affairs (I01CX001932)
- University of Iowa Roy J and Lucille A Carver College of Medicine
- National Heart, Lung, and Blood Institute (T32 HL007344, R01 AI162778, HL068835, HL168630)
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- Roy J. Carver Charitable Trust
This publication has 30 references indexed in Scilit:
- Extracellular histones: a unifying mechanism driving platelet-dependent extracellular vesicle release and thrombus formation in COVID-19Journal of Thrombosis and Haemostasis, 2024
- Dysregulation of Protein S in COVID-19Best Practice & Research Clinical Haematology, 2022
- Understanding COVID-19-associated coagulopathyNature Reviews Immunology, 2022
- Increased histone-DNA complexes and endothelial-dependent thrombin generation in severe COVID-19Vascular Pharmacology, 2021
- Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathyJournal of Thrombosis and Thrombolysis, 2021
- Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infectioneClinicalMedicine, 2021
- Thrombotic potential during pediatric acute lymphoblastic leukemia induction: Role of cell‐free DNAResearch and Practice in Thrombosis and Haemostasis, 2021
- Prognostic value of thrombin generation parameters in hospitalized COVID-19 patientsScientific Reports, 2021
- Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and Protein SResearch and Practice in Thrombosis and Haemostasis, 2018
- Plasma Levels of Total and Free Tissue Factor Pathway Inhibitor (TFPI) as Individual Pharmacological Parameters of Various HeparinsThrombosis and Haemostasis, 2001